Our website uses necessary cookies to enable basic functions and optional cookies to help us to enhance your user experience. Learn more about our cookie policy by clicking "Learn More".
Accept All Only Necessary Cookies
HEM-POWR Study 아이콘

1.0 by MicroHealth Inc


Oct 30, 2019

HEM-POWR Study 정보

HEM-POWR 연구에 참여하는 혈우병 A 환자

HEM-POWR App is intended solely for the participants in the HEM-POWR study in the United States: Observational Study Evaluating Effectiveness and Safety of Real-World Treatment with Damoctocog alfa pegol in Previously Treated Patients with Hemophilia A.

The purpose of the app is to help the participants to answer the electronic Patient-Reported Outcomes Questionnaires which are part of your participation in the HEM-POWR study.

Utilizing MicroHealth and HEM-POWR App is absolutely voluntary and your decision to use or not use it will neither affect your participation in the HEM-POWR study nor the standard medical care for you / your child.

This tool includes electronic reminders concerning Patient-Reported Outcomes Questionnaires, a personal and password-protected database for entry, and features to permit those involved in the HEM-POWR study to get relevant reports FOR NON-EMERGENCY REASONS ONLY.

If you think you may have a medical emergency, call your doctor or 911 immediately. MicroHealth and HEM-POWR do not recommend or endorse any specific products, physicians, procedures, opinions, or other information that may be mentioned on the Site.

번역 로드 중...

추가 앱 정보

최신 버전

HEM-POWR Study 업데이트 요청 1.0

필요한 Android 버전

4.3 and up

Available on

Google Play에서 HEM-POWR Study 얻기

더 보기

최신 버전 1.0의 새로운 기능

Last updated on Oct 30, 2019

Minor bug fixes and improvements. Install or update to the newest version to check it out!

더 보기

HEM-POWR Study 스크린 샷

댓글 로드 중 ...
APKPure를 구독하십시오
최고의 Android 게임 및 앱의 초기 릴리스, 뉴스 및 가이드에 액세스하는 첫 번째 사람이 되십시오.
고맙지 만 사양 할게
가입하기
성공적으로 구독!
당신은 이제 APKPure에 가입되었습니다.
APKPure를 구독하십시오
최고의 Android 게임 및 앱의 초기 릴리스, 뉴스 및 가이드에 액세스하는 첫 번째 사람이 되십시오.
고맙지 만 사양 할게
가입하기
성공!
당신은 이제 우리의 뉴스 레터를 구독하고 있습니다.